FAMICORD AG (V3V.DE) Stock Fundamental Analysis
Europe - FRA:V3V - DE000A0BL849 - Common Stock
6.65 EUR
-0.05 (-0.75%)
Overall V3V gets a fundamental rating of 3 out of 10. We evaluated V3V against 27 industry peers in the Health Care Providers & Services industry. V3V has a bad profitability rating. Also its financial health evaluation is rather negative. V3V is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year V3V was profitable.
V3V had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: V3V reported negative net income in multiple years.
V3V had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
V3V has a Return On Assets (1.61%) which is in line with its industry peers.
V3V has a Return On Equity of 10.63%. This is in the better half of the industry: V3V outperforms 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.61% | ||
| ROE | 10.63% | ||
| ROIC | N/A |
ROA(3y)-7.04%
ROA(5y)-3.48%
ROE(3y)-60.2%
ROE(5y)-34.49%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a Profit Margin value of 3.20%, V3V perfoms like the industry average, outperforming 55.56% of the companies in the same industry.
With a Gross Margin value of 36.66%, V3V perfoms like the industry average, outperforming 59.26% of the companies in the same industry.
V3V's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | 3.2% | ||
| GM | 36.66% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.67%
GM growth 5Y-8.9%
2. Health
2.1 Basic Checks
V3V does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for V3V has been increased compared to 1 year ago.
The number of shares outstanding for V3V has been increased compared to 5 years ago.
The debt/assets ratio for V3V has been reduced compared to a year ago.
2.2 Solvency
V3V has an Altman-Z score of 0.65. This is a bad value and indicates that V3V is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.65, V3V is doing worse than 74.07% of the companies in the same industry.
The Debt to FCF ratio of V3V is 2.09, which is a good value as it means it would take V3V, 2.09 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 2.09, V3V belongs to the best of the industry, outperforming 96.30% of the companies in the same industry.
V3V has a Debt/Equity ratio of 0.56. This is a neutral value indicating V3V is somewhat dependend on debt financing.
V3V has a better Debt to Equity ratio (0.56) than 77.78% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.56 | ||
| Debt/FCF | 2.09 | ||
| Altman-Z | 0.65 |
ROIC/WACCN/A
WACC6.47%
2.3 Liquidity
A Current Ratio of 0.76 indicates that V3V may have some problems paying its short term obligations.
V3V has a Current ratio of 0.76. This is in the lower half of the industry: V3V underperforms 77.78% of its industry peers.
A Quick Ratio of 0.70 indicates that V3V may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.70, V3V is doing worse than 66.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.76 | ||
| Quick Ratio | 0.7 |
3. Growth
3.1 Past
V3V shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 109.51%, which is quite impressive.
The Revenue has been growing slightly by 7.73% in the past year.
Measured over the past years, V3V shows a very strong growth in Revenue. The Revenue has been growing by 30.44% on average per year.
EPS 1Y (TTM)109.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%160%
Revenue 1Y (TTM)7.73%
Revenue growth 3Y57.65%
Revenue growth 5Y30.44%
Sales Q2Q%8.91%
3.2 Future
V3V is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 30.68% yearly.
V3V is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.88% yearly.
EPS Next Y58.33%
EPS Next 2Y38.44%
EPS Next 3Y34.2%
EPS Next 5Y30.68%
Revenue Next Year9.33%
Revenue Next 2Y8.01%
Revenue Next 3Y6.85%
Revenue Next 5Y2.88%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
V3V is valuated quite expensively with a Price/Earnings ratio of 47.50.
V3V's Price/Earnings ratio is a bit more expensive when compared to the industry. V3V is more expensive than 70.37% of the companies in the same industry.
V3V is valuated expensively when we compare the Price/Earnings ratio to 27.43, which is the current average of the S&P500 Index.
V3V is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 47.5 | ||
| Fwd PE | N/A |
4.2 Price Multiples
70.37% of the companies in the same industry are cheaper than V3V, based on the Enterprise Value to EBITDA ratio.
The rest of the industry has a similar Price/Free Cash Flow ratio as V3V.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 13.07 | ||
| EV/EBITDA | 14.01 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
V3V's earnings are expected to grow with 34.20% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.81
PEG (5Y)N/A
EPS Next 2Y38.44%
EPS Next 3Y34.2%
5. Dividend
5.1 Amount
V3V does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:V3V (9/11/2025, 7:00:00 PM)
6.65
-0.05 (-0.75%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners11.26%
Inst Owner ChangeN/A
Ins Owners58.45%
Ins Owner ChangeN/A
Market Cap117.31M
Analysts84
Price Target6.63 (-0.3%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 47.5 | ||
| Fwd PE | N/A | ||
| P/S | 1.45 | ||
| P/FCF | 13.07 | ||
| P/OCF | 9.69 | ||
| P/B | 4.83 | ||
| P/tB | N/A | ||
| EV/EBITDA | 14.01 |
EPS(TTM)0.14
EY2.11%
EPS(NY)-0.01
Fwd EYN/A
FCF(TTM)0.51
FCFY7.65%
OCF(TTM)0.69
OCFY10.32%
SpS4.57
BVpS1.38
TBVpS-1.68
PEG (NY)0.81
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.61% | ||
| ROE | 10.63% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | 3.2% | ||
| GM | 36.66% | ||
| FCFM | 11.13% |
ROA(3y)-7.04%
ROA(5y)-3.48%
ROE(3y)-60.2%
ROE(5y)-34.49%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.67%
GM growth 5Y-8.9%
F-Score7
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.56 | ||
| Debt/FCF | 2.09 | ||
| Debt/EBITDA | 1.65 | ||
| Cap/Depr | 35.61% | ||
| Cap/Sales | 3.89% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 147.25% | ||
| Profit Quality | 347.6% | ||
| Current Ratio | 0.76 | ||
| Quick Ratio | 0.7 | ||
| Altman-Z | 0.65 |
F-Score7
WACC6.47%
ROIC/WACCN/A
Cap/Depr(3y)60.39%
Cap/Depr(5y)47.49%
Cap/Sales(3y)7.53%
Cap/Sales(5y)6.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)109.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%160%
EPS Next Y58.33%
EPS Next 2Y38.44%
EPS Next 3Y34.2%
EPS Next 5Y30.68%
Revenue 1Y (TTM)7.73%
Revenue growth 3Y57.65%
Revenue growth 5Y30.44%
Sales Q2Q%8.91%
Revenue Next Year9.33%
Revenue Next 2Y8.01%
Revenue Next 3Y6.85%
Revenue Next 5Y2.88%
EBIT growth 1Y97.38%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year562.86%
EBIT Next 3Y100.95%
EBIT Next 5Y74.16%
FCF growth 1Y198.46%
FCF growth 3Y20.6%
FCF growth 5Y6%
OCF growth 1Y520.19%
OCF growth 3Y37.37%
OCF growth 5Y14.78%